Thomas Sandgaard

Thomas Sandgaard is a Danish entrepreneur and inventor based out of Colorado.[1][2][3][4][5] Sandgaard is known as the founder and CEO of Zynex Inc. In 2012, he was nominated for the Entrepreneur of the Year by Ernst & Young.[6][7]

Thomas Sandgaard
Born
Denmark
NationalityAmerican
EducationMBA
Alma materCopenhagen Business School
OccupationEntrepreneur, inventor
Years active1996-present
Known forCharlton Athletic, Zynex Inc

Career

Sandgaard was born and raised in Denmark. He obtained his BSc in electrical and electronics engineering from University of Southern Denmark. He graduated from Copenhagen Business School with an MBA degree in marketing. In 1996, he moved to the United States and later in 2018, he gained US citizenship.[8]

In 1996, he founded Zynex Inc in Englewood, Colorado, which became the manufacturer for electrotherapy devices for use in non-invasive, drug-free pain management, neurological diagnosis and non-invasive cardiac monitoring.[9] In August 2018, he founded The Sandgaard Foundation with a goal to end the opioid epidemic and save lives from opioid overdose.[10]

In September 2020, Sandgaard became owner of Charlton Athletic F.C..[11]

Patents obtained by Thomas Sandgaard
  • Method and apparatus for non-invasively detecting blood volume imbalances in a mammalian subject (20190150761), 2019[12]
  • Methods and apparatus for estimating a blood volume of a mammalian subject (20120016246), 2012[13]
  • Electromyogram-triggered neuromuscular stimulation device and method (20050113883), 2005[14]

References
  1. "Charlton trust will take time - Sandgaard". BBC Sport. Retrieved 9 September 2020.
  2. "Charlton boost as wealthy businessman plots purchase of crisis club". Evening Standard. 14 August 2020. Retrieved 9 September 2020.
  3. "Dansker vil betale 400 millioner for engelsk traditionsklub". FINANS (in Danish). 17 August 2020. Retrieved 9 September 2020.
  4. "Method and apparatus for non-invasively detecting blood volume imbalances in a mammalian subject - Patent US10136822 - PubChem". pubchem.ncbi.nlm.nih.gov. National Library of Medicine. Retrieved 14 August 2020.
  5. "Thomas Sandgaard Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com.
  6. "Zynex's Thomas Sandgaard says stubbornness serves him well". www.bizjournals.com. Retrieved 14 August 2020.
  7. "Zynex President and CEO, Thomas Sandgaard Nominated as Ernst & Young LLP Entrepreneur of the Year® 2012 Finalist in the Mountain Desert Region". BioSpace. Retrieved 14 August 2020.
  8. "Who We Are". The Sandgaard Foundation.
  9. "This Colorado CEO plays guitar, but it's his addiction-destroying device that's the rock star". www.bizjournals.com. Retrieved 14 August 2020.
  10. "Tighter focus, additional funding crucial to combat opioid crisis, group says". dispatch.com. Retrieved 14 August 2020.
  11. https://www.cafc.co.uk/news/view/5f6de1155eab9/thomas-sandgaard-acquires-charlton-athletic-football-club
  12. "METHOD AND APPARATUS FOR NON-INVASIVELY DETECTING BLOOD VOLUME IMBALANCES IN A MAMMALIAN SUBJECT". patents.justia.com. Retrieved 14 August 2020.
  13. "METHODS AND APPARATUS FOR ESTIMATING A BLOOD VOLUME OF A MAMMALIAN SUBJECT". patents.justia.com. Retrieved 14 August 2020.
  14. "Electromyogram-triggered neuromuscular stimulation device and method". patents.justia.com. Retrieved 14 August 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.